2nd Quarter - Report

COLBY & COMPANY for BIOOHIO

Firm
Client
Income
$6,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

We contacted the offices of: Congresswoman Sutton, Congressman Space, Congressman Boccieri, and Senator Brown regarding BioOhio's support for biomanufacturing in Ohio.

LobbyistCovered position, as disclosed
TIMOTHY CASSELL —
RICHARD COLBY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Economics/Economic Development ECN

Pursuing appropriations for the bioscience industry in Ohio. We contacted the offices of: Congresswoman Sutton, Congressman Space, Congressman Boccieri, and Senator Brown regarding BioOhio's support for: biomanufacturing; workforce development; the BioBus program.

LobbyistCovered position, as disclosed
TIMOTHY CASSELL —
RICHARD COLBY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Pursuing appropriations for the bioscience industry in Ohio. We contacted the offices of: Congresswoman Sutton, Congressman Space, Congressman Boccieri, and Senator Brown regarding BioOhio's support for: biomanufacturing; workforce development; the BioBus program.

LobbyistCovered position, as disclosed
TIMOTHY CASSELL —
RICHARD COLBY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]

LobbyistCovered position, as disclosed
RICHARD COLBY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1260 (111th), S. 726 (111th), H.R. 1548 (111th), H.R. 1427 (111th), S. 515 (111th)

Pharmacy PHA

Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]

LobbyistCovered position, as disclosed
RICHARD COLBY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1260 (111th), H.R. 1548 (111th), H.R. 1427 (111th), S. 515 (111th), S. 726 (111th)

Medical/Disease Research/Clinical Labs MED

Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]

LobbyistCovered position, as disclosed
RICHARD COLBY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 515 (111th), H.R. 1427 (111th), H.R. 1260 (111th), H.R. 1548 (111th), S. 726 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.